| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703105 | Null | 0.00265144454581183 | 0.1434378 |
| NSC 703109 | Null | 0.00265144454581183 | 0.15569721 |
| NSC 707904 | Null | 0.00265144454581183 | 0.32423364 |
| NSC 709483 | Null | 0.00265144454581183 | 0.29958262 |
| NSC 714379 | Null | 0.00265144454581183 | 0.069226226 |
| NSC 720386 | Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane | 0.00265144454581183 | 0.36550574 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.00265144454581183 | 0.15281483 |
| NSC 733504 | Everolimus | 0.00265144454581183 | -0.10005234 |
| NSC 740024 | 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine | 0.00265144454581183 | 0.25446001 |
| NSC 743528 | Null | 0.00265144454581183 | 0.2931661 |